First data in African subjects for the monovalent Janssen Ebola Zaire heterologous prime-boost vaccines, combining Ad26.ZEBOV and MVA-BN-Filo. (December 2016) - Anzala, O.; Mutua, G.; Nyaoke, B.; Robinson, C.; Luhn, K.; Callendret, B.; Thiebaut, R.; Snape, M.; Watson-Jones, D.; Douoguih, M.